meta_pixel
Tapesearch Logo
Log in
The Addicted Mind Podcast

45:Psychedelics & Post Traumatic Stress Disorder with Amy Emerson and Shannon Carlin

The Addicted Mind Podcast

Duane Osterlind, LMFT

Health & Fitness, Medicine, Mental Health

4.8621 Ratings

🗓️ 16 August 2018

⏱️ 39 minutes

🧾️ Download transcript

Summary

On this episode of The Addicted Mind, we are joined by Amy Emerson and Shannon Carlin of the Multidisciplinary Approach for Psychedelic Studies (MAPS) research group. Amy and Shannon’s group has had 107 participants complete their MDMA-assisted PTSD therapy program in the last several years, with promising results. As you may know, PTSD (Post-Traumatic Stress Disorder) affects 7% of the US population who have experienced life-threatening events such as military combat, car accidents, natural disasters, or childhood abuse. Individuals with PTSD experience prolonged instability in their lives, perhaps resulting in hypervigilance, fear, difficulty sleeping, and lack of trust.

MDMA, the active ingredient in ecstasy, allows participants to experience the opposite of their PTSD symptoms, ideally increasing trust and dampening fear. Participants go through 3 previous therapy visits to establish a baseline and get them familiar with the therapy process, then they have their first MDMA session, followed by 3 integrative sessions, their second MDMA session, 3 more integrative sessions, and then their final MDMA session and 3 integrative sessions. Overall, the therapy sessions span 12-15 weeks, and though the courses are quite intense, participants have found this method to be less invasive and retraumatizing than their previous experiences with talk therapy.

During their MDMA sessions, participants will spend 8 hours with 2 therapists who will guide the participant to follow their inner process by listening to their internal healing intelligence. This could mean that the participant talks a lot or barely at all during the session, but the purpose of the subsequent integrative visits is to help the participant process what they experienced and develop the new perspectives that they may be feeling in terms of life in general, coping with their trauma, work, and relationships.


The MAPS research group’s research has shown that 2 months after completing their last therapy session, 56% of participants no longer had PTSD, while 12 months after finishing their therapy, 68% no longer had PTSD. Participants have been pleasantly surprised by their results and healing, and therapists are observing the sessions and effects have been amazed at its effectiveness.

To anyone who has been seeking help and been discouraged with your progress, Amy and Shannon want you to know that there is hope and research advances are providing new treatment options to the field faster than ever before. Keep seeking help until you find the right fit for you.



Support this podcast at — https://redcircle.com/the-addicted-mind-podcast/donations

Learn more about your ad choices. Visit megaphone.fm/adchoices

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Transcript

Click on a timestamp to play from that location

0:00.0

Hello everyone. Welcome to the Addicted Mind podcast. My name's Dwayne Austerland, and I'm your host, and I'm also the founder of Novis Mindful Life Institute, Family Counseling Recovery Center in Long Beach, California.

0:18.1

If you or anyone you know is struggling with any of life's difficulties,

0:23.5

please reach out to us for help. You can find more information about us at theadictedmind.com

0:29.5

forward slash help. Okay, we're on to episode of 45 and I have two wonderful guests today,

0:37.0

Shannon Carlin and Amy Emerson. And they are going to

0:41.1

talk about their current research they're doing with psychedelics and post-traumatic stress disorder.

0:47.7

Now, I found this really fascinating because post-traumatic stress disorder can be really difficult to treat, and there's not necessarily a ton of success.

0:59.0

So their studies that they're showing, the preliminary results, are very promising.

1:04.5

And with this study, particularly, they're using MDMA, which is also known as Ecstasy or Molly, to help people move through their

1:14.3

post-traumatic symptoms. So it's very exciting to see the results that they're showing. And also,

1:22.1

just to talk with them about it, about how this process works and how this is really helping people who are struggling

1:30.5

with this really difficult mental health issue. So I was so happy that they came on and they

1:37.0

are willing to talk about their research and what they're doing. So without further ado,

1:43.4

let's start this episode.

1:50.3

Okay, everybody, welcome to the Addicted Mind. I've got two great guests today, and they're

1:55.5

going to talk about a subject that I am finding really fascinating, and that is the psychedelic studies of working with

2:04.4

post-traumatic stress disorder and helping people use that to kind of overcome that and work

2:12.4

through it. So Shannon and Amy, you guys want to introduce yourselves? Yeah, Amy, you want to go first?

2:18.9

Sure.

2:20.1

I'm Amy Emerson, and I'm the head of the clinical research group and regulatory affairs for the

2:25.4

MAPS Public Benefit Corporation.

2:28.1

The MAPS Public Benefit Corporation is a wholly owned subsidiary of MAPS, and MAPS is the

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Duane Osterlind, LMFT, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Duane Osterlind, LMFT and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.